Skip to main content

Table 2 Comparisons of clinical baseline features

From: miR-182-5p combined with brain-derived neurotrophic factor assists the diagnosis of chronic heart failure and predicts a poor prognosis

Feature

Controls

CHF

P value

(N = 78)

(N = 82)

Age (year)

65.44 ± 1.41

64.93 ± 1.44

0.887

Gender (male/female)

41/37

45/37

0.770

BMI (kg/m2)

24.96 ± 0.325

25.07 ± 0.345

0.988

Smoking history (never/ever)

61/17

68/14

0.453

Drinking history (never/ever)

54/24

57/25

0.969

TC (nM)

4.65 ± 0.18

4.62 ± 0.17

0.282

TG (nM)

1.34 ± 0.63

1.42 ± 0.66

0.439

LDL-C (nM)

2.93 ± 0.15

3.05 ± 0.13

0.865

HDL-C (nM)

1.17 ± 0.33

1.18 ± 0.05

0.781

UA (µM)

355.23 ± 14.95

352.38 ± 13.51

0.207

BNP (ng/l)

66.57 ± 20.93

1564.595 ± 875.43

 < 0.001

LVEF (%)

58.76 ± 0.64

29.93 ± 3.52

 < 0.001

Complication (no/yes)

Hypertension

44/34

57/25

0.0870

Diabetes

47/31

53/29

0.5704

COPD

–

69/13

–

Anemia

–

 

–

Fluid and electrolyte imbalance

–

45/37

–

NYHA stage

I

–

15

–

II

–

29

–

III

–

27

–

IV

–

11

–

  1. Data were expressed as mean ± standard deviation or N
  2. CHF, chronic heart failure; BMI, body mass index; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; UA, uric acid; BNP, brain natriuretic peptide; LVEF, left ventricle ejection fraction; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association